01 / DESIGN
What was studied?
Patient biomarker observations were combined with mouse receptor-knockout experiments and human endothelial-cell assays.
02 / FINDINGS
What did the researchers report?
Lower circulating levels were observed in patients; experimentally administered peptide reduced selected aneurysm-related findings in wild-type mice but not receptor-deficient mice.
03 / LIMITS
How should it be interpreted?
The human component was observational and the intervention evidence was preclinical. These two parts cannot be combined into a claim that the peptide prevents human aneurysms.
Voltera Peptide editorial reading note. Based on the linked source record. Methods and corrections.